Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials

Ravani, LV; Gewehr, DM; Calomeni, P; Gauza, MD; Pereira, J; Cardoso, R; Ribeiro, HB; Bocchi, E

Ravani, LV (通讯作者),Univ Sao Paulo, Med Sch, Dept Med, Sao Paulo, Brazil.

AMERICAN JOURNAL OF CARDIOLOGY, 2023; 205 ():

Abstract

Sacubitril-valsartan is an angiotensin receptor-neprilysin inhibitor (ARNI) associated (HF). However, its association with improved atherosclerotic ca......

Full Text Link